XCath Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

XCath General Information

Description

Developer of advanced endovascular robotics and steerable guidewires designed to enhance precision in navigating the vascular system. The company offers tools for minimally invasive treatment of complex vascular conditions, enabling doctors to improve clinical outcomes, ensure safer procedures, and achieve faster recovery times.

Contact Information

Website
www.xcath.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9330 Kirby Drive
  • Suite 900
  • Houston, TX 77054-2595
  • United States
+1 (281)
Primary Industry
Surgical Devices
Other Industries
Other Hardware
Vertical(s)
Corporate Office
  • 9330 Kirby Drive
  • Suite 900
  • Houston, TX 77054-2595
  • United States
+1 (281)

XCath Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XCath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Jun-2026 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series C) 12-Mar-2026 Completed Clinical Trials - Phase 1
3. Later Stage VC Completed Clinical Trials - Phase 1
2. Later Stage VC (Series B) 20-Jan-2022 $24M $29.3M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 08-Mar-2017 $5.33M $5.33M Completed Clinical Trials - Phase 1
To view XCath’s complete valuation and funding history, request access »

XCath Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-5
Series B-4
Series B-3
Series B-2
Series B-1 9,100,000 $0.000010 $0.55 $0.55 1x $0.55 14.12%
Series A 13,257,203 $0.000010 $0.4 $0.4 1x $0.4 20.57%
To view XCath’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

XCath Patents

XCath Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026159544-A1 Method of guiding catheter and guiding device Pending 23-Jan-2025
WO-2026150301-A1 System for guiding intravascular insertion device Pending 08-Jan-2025
WO-2026146380-A1 Method for providing graphic user interface displaying cassette driving module, and graphic user interface Pending 02-Jan-2025
WO-2026120520-A1 Guide wire-driving cassette Pending 04-Dec-2024
WO-2026053015-A1 Module for guiding at least one of guidewire or catheter Pending 06-Sep-2024
To view XCath’s complete patent history, request access »

XCath Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XCath Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Crescent Enterprises Corporation Minority
Angel (individual) Minority
To view XCath’s complete investors history, request access »

XCath FAQs

  • When was XCath founded?

    XCath was founded in 2017.

  • Where is XCath headquartered?

    XCath is headquartered in Houston, TX.

  • What is the size of XCath?

    XCath has 50 total employees.

  • What industry is XCath in?

    XCath’s primary industry is Surgical Devices.

  • Is XCath a private or public company?

    XCath is a Private company.

  • What is XCath’s current revenue?

    The current revenue for XCath is .

  • How much funding has XCath raised over time?

    XCath has raised $95.4M.

  • Who are XCath’s investors?

    Crescent Enterprises and have invested in XCath.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process